Loading provider…
Loading provider…
Cardiovascular Disease Physician in Nashville, TN
NPI: 1194817502Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD Macrae's Phone Numberphone_androidMobile
Get MD Macrae's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License
TN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 43 | 52 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 16 | 16 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 12 |
Authors: Sanjay Srivastava, Yang Lee
Journal: Circ Res
Authors: Huang, Jiansheng, Tao, Huan, Yancey, Patricia G, Leuthner, Zoe, May-Zhang, Linda S, Jung, Ju-Yang, Zhang, Youmin, Ding, Lei, Amarnath, Venkataraman, Liu, Dianxin, Collins, Sheila, Davies, Sean S, Linton, MacRae F
Journal: Mol Metab
Publication Date: 2022-12-05
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: TQJ230
Lead Sponsor: REGENXBIO Inc.
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Intervention / Treatment: GENETIC: AAV directed hLDLR gene therapy
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: Fenofibrate, DRUG: Rosuvastatin, DRUG: Atorvastatin, DRUG: Omega-3 fatty acids, DRUG: Ezetimibe, DRUG: Simvastatin, DRUG: Lovastatin, DRUG: Fluvastatin, DRUG: Alirocumab SAR236553 (REGN727), DRUG: Pravastatin, DRUG: Cholestyramine, DRUG: Nicotinic acid